
ResMed (RMD) Stock Forecast & Price Target
ResMed (RMD) Analyst Ratings
Bulls say
ResMed is a leading respiratory care device company, with a focus on developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. The company is well-positioned in a structurally growing market, with increasing diagnosis of sleep apnea, aging populations, and rising rates of obesity. Recent developments and acquisitions in digital health indicate ResMed's focus on differentiation and expanding its market reach. Overall, the company's financials and growth potential, combined with its strategic initiatives, suggest a positive outlook for the stock.
Bears say
ResMed is facing challenges with its gross margin miss in 4Q26 and projections of a slight YoY contraction in gross margin in 1Q27, driven by inflation and higher freight costs. Additionally, the uncertainty surrounding the impact of GLP-1 drugs on the company's growth opportunities adds further concern to the long-term outlook. While the company's recent focus on digital health and potential market growth may seem promising, the negative financial trends and potential industry disruptors make for a challenging outlook.
This aggregate rating is based on analysts' research of ResMed and is not a guaranteed prediction by Public.com or investment advice.
ResMed (RMD) Analyst Forecast & Price Prediction
Start investing in ResMed (RMD)
Order type
Buy in
Order amount
Est. shares
0 shares